Climate Change Data

Environmental Metrics

Social Achievements

• Geratherm warming systems obtain FDA approval and are selected in Germany as one of the ten best products, with the best saving potential in the healthcare sector.
• The cardio field, covered by apoplex in Pirmasens, was awarded the innovation prize from the state of Rhineland-Palatinate.
• Geratherm wins an exclusive contract to supply the US military with warming systems for use in rescues.

Climate Goals & Targets

Environmental Challenges

• Sharp drop in demand for gallium thermometers in 2012
• Drastic slump in raw material price of gallium over the year, from 850 USD to 300 USD per kilogram.
• The state of Thuringia informed us that the registration office for Geratherm and its products would be closed midway through the year.
• The EU initiative to recertify and revise all electronic medical devices, the so-called “Third Edition”, hindered the majority of our management capacities.
• Very mild temperatures for the first time in a long while and there was no flu epidemic in Europe during winter 2011/2012.

Mitigation Strategies

• Capacity adjustment at the Geschwenda factory for the production of gallium thermometers.
• Company underwent recertification as well as all Geratherm Medical products.
• Software and hardware reconfiguration as part of the so-called Third Edition exercise, due to the new EU stipulation on marketing of medical products.
• Short-time work in the 1st quarter of 2012 at the Geschwenda factory.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: IFRS

Third-party Assurance: KPMG AG

Sustainable Products & Innovation

• Environmentally friendly analogue clinical thermometer filled with gallium

Environmental Metrics

ESG Focus Areas

• Not disclosed

Environmental Achievements

• World market leader in mercury-free analog clinical glass thermometers (contributing 37% to overall sales in 2021)

Social Achievements

• Not disclosed

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Supply bottlenecks leading to limited availability of electronic components and circuit boards
• Significant price increases in gas (energy source for glass production)
• Increasing minimum wage in Germany
• A few suppliers and some sales in regions affected by the Ukraine-Russia war

Mitigation Strategies

• Signed agreements with suppliers to fix prices for a certain period
• Invested in a new production facility for medical capillaries, substituting suppliers

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Mercury-free analog thermometers

Awards & Recognition

• Not disclosed

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

• Supply bottlenecks leading to limited availability of electronic components and circuit boards.
• Significant price increases in gas (energy source for glass production).
• Increasing minimum wage in Germany.
• A few suppliers and some sales in regions affected by the Ukraine-Russia war.

Mitigation Strategies

• Signed agreements with suppliers to fix prices for a certain period.
• Invested in a new production facility for medical capillaries, substituting suppliers.

Supply Chain Management

Climate-Related Risks & Opportunities

Sustainable Products & Innovation

• Mercury-free analog clinical glass thermometer

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

• Declining sales in the Healthcare Diagnostics business unit due to increasing competition from Asia.
• Sales of clinical thermometers below plan due to an unusually mild winter.

Mitigation Strategies

• Application for short-time work at the Geratal plant from April 1, 2024 to October 31, 2024 to reduce inventories.

Supply Chain Management

Climate-Related Risks & Opportunities

Environmental Metrics

Environmental Challenges

• Ongoing challenges in the clinical thermometer market, with sales plummeting by 47% year-on-year in the first half of 2024 due to competition from imported thermometers from China that often fail to meet EU MDR standards.

Mitigation Strategies

• Geratherm has extended short-time work for its Geratal facility until March 31, 2025. The company intends to shift its focus to the end consumer to strengthen the Geratherm brand.

Supply Chain Management

Climate-Related Risks & Opportunities

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

• Input price inflation, especially for energy, resulting in a gross margin decline.
• Increase in the statutory hourly minimum wage.
• Supply chain issues leading to declining yoy revenues in H1 (for Respiratory segment).

Supply Chain Management

Climate-Related Risks & Opportunities

Environmental Metrics

Governance Achievements

• Obtained MDR certification for analogue clinical thermometers.

Climate Goals & Targets

Environmental Challenges

• 19% drop in sales due to significant declines in Healthcare Diagnostics (-29% yoy) and Respiratory (-10% yoy).
• Continued challenges in Healthcare Diagnostics, particularly with clinical thermometers due to mild winter and increasing competition from China.
• Short-time working at the Geratal plant from 1 April 2024 to 31 October 2024 to reduce inventories.

Mitigation Strategies

• Effective cost management (flat personnel costs and declining administration costs) resulting in a slight increase in EBIT.
• Application for short-time working at the Geratal plant to reduce inventories.
• MDR certification for analogue clinical thermometers to potentially regain market share.

Supply Chain Management

Climate-Related Risks & Opportunities

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

• Sluggish sales in H1 2023, declining by 6.7% compared to the previous year across all segments except Cardio/Stroke. Increasing competition from Asia in the Healthcare Diagnostic segment (56% of sales). Supply chain issues limited shipments in the Respiratory segment.

Mitigation Strategies

• Introduced price increases to compensate for rising input costs. Strict OPEX management, including a 13% headcount reduction to offset higher statutory minimum hourly wages in Germany. Supply chain issues in Respiratory segment expected to be resolved in H2.

Supply Chain Management

Climate-Related Risks & Opportunities